EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Zebrafish xenograft models as a fast platform for metastasis diagnosis and cisplatin response of head and neck squamous cell carcinoma

Lu Chen, Shu Sun, Yujia Liu, Liehao Jiang, Cuiyun Wu, Ting Liu, Yujiao Zhao, Yuwei Liu, Lu Liu, Qi Wang, Xiaowei Zheng, Ping Huang iD

Animal Models and Experimental Medicine · 2026

DOI: 10.1002/ame2.70282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Lu Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou M…. Hauptthemen laut MEDLINE: Zebrafish, Cisplatin, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the NSFC Projects of International Cooperation and Exchanges, the Zhejiang Provincial Science and Technology Program, the Central Government Guides Local Science and Technology Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck squamous cell carcinoma (HNSCC) is characterized by clinically undetectable early metastasis and a poor prognosis at locally advanced and recurrent metastatic stages. Platinum‐based resistance remains a major limitation to treatment efficacy. Currently, no reliable biomarkers are available to identify lymph node metastasis or to predict therapeutic sensitivity. Therefore, this study aimed to develop a predictive model to address these clinical challenges.

Methods

Four cell lines (CAL‐27, FaDu, Leuk1, NOEC) were employed to establish zebrafish cell‐derived xenograft (zCDX) models and assess the differential metastatic potential. Surgical or biopsy samples from, respectively, 20 and 14 HNSCC patients were used for building and validating the zebrafish patient‐derived xenograft (zPDX) models. Cisplatin‐sensitive HNSCC cell lines (CAL‐27 and FaDu) and their cisplatin‐resistant sublines (CAL‐27‐DDP and FaDu‐DDP) were established, and the differential responses to cisplatin were evaluated in both murine and zCDX models. Additionally, to assess the patient‐specific therapeutic efficacy of cisplatin, zPDX models were generated from four patient‐derived surgical specimens and a supplementary biopsy for preliminary validation.

Results

The zebrafish xenograft model recapitulated the invasive phenotype of the HNSCC cell lines. The model distinguished between metastatic and non‐metastatic disease with high accuracy (AUC = 0.98). It faithfully reproduced the cisplatin sensitivity and resistance patterns identified in corresponding in vitro and murine models. Moreover, it showed strong concordance with patient‐specific cisplatin responses.

Conclusions

The zPDX model provides a rapid, efficient, clinically applicable platform for predicting metastasis and evaluating platinum‐based therapy responses in HNSCC, facilitating the design of scientifically grounded personalized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishCisplatinHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckAntineoplastic AgentsXenograft Model Antitumor AssaysAnimalsHumansCell Line, TumorFemaleNeoplasm MetastasisDrug Resistance, NeoplasmMiceDisease Models, AnimalMale

Stichwörter der Autor:innen

PDX modelcisplatin responsehead and neck squamous cell carcinomametastasis predictionzebrafish

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Department of Radiology, Zhejiang Provincial People's Hospital, Hangzhou, China.

ORCID-Profile: Ping Huang

Förderung

  • the NSFC Projects of International Cooperation and Exchanges
  • the Zhejiang Provincial Science and Technology Program
  • the Central Government Guides Local Science and Technology Development Funds

Zitieren

APA

Chen, L., Sun, S., Liu, Y., Jiang, L., Wu, C., Liu, T., Zhao, Y., Liu, Y., Liu, L., Wang, Q., Zheng, X., & Huang, P. (2026). Zebrafish xenograft models as a fast platform for metastasis diagnosis and cisplatin response of head and neck squamous cell carcinoma. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70282

Vancouver

Chen L, Sun S, Liu Y, Jiang L, Wu C, Liu T, et al. Zebrafish xenograft models as a fast platform for metastasis diagnosis and cisplatin response of head and neck squamous cell carcinoma. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70282

BibTeX
@article{Chen2026,
  author = {Chen, Lu and Sun, Shu and Liu, Yujia and Jiang, Liehao and Wu, Cuiyun and Liu, Ting and Zhao, Yujiao and Liu, Yuwei and Liu, Lu and Wang, Qi and Zheng, Xiaowei and Huang, Ping},
  title = {Zebrafish xenograft models as a fast platform for metastasis diagnosis and cisplatin response of head and neck squamous cell carcinoma},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  doi = {10.1002/ame2.70282}
}
Kostenlos starten →